A renewed focus on glaucoma comes with each new year, as January is Glaucoma Awareness Month.Glaucoma has been estimated to ...
SpyGlass Pharma has randomized the first patients in its 2 registrational phase 3 clinical trials of the Bimatoprost Drug Pad-IOL System (BIM-IOL System) for the lowering of intraocular pressure (IOP) ...
Despite updated understandings of IOP and glaucoma risk, cutoff values are still a primary influence on treatment ...
To yield the benefits of interventional glaucoma treatment, ophthalmologists need a roadmap for how to implement it, according to a speaker here. At the Hawaiian Eye 2026 meeting, Christine Funke, MD, ...
A nationwide study of 11 million patients confirms the risk of acute angle closure after pharmacologic dilation is extremely low.
The axial length/corneal radius ratio may be an effective diagnostic tool for identifying myopia in pediatric patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results